Navigation Links
ReShape Medical Appoints Robert E. Grant to Board of Directors
Date:6/21/2012

SAN CLEMENTE, Calif., June 21, 2012 /PRNewswire/ -- ReShape Medical, a company focused on a non-surgical weight loss device, announced today that Robert E. Grant will join its board of directors.

(Photo:  http://photos.prnewswire.com/prnh/20120621/LA28274)

Grant currently serves as chairman of Strathspey Crown LLC, a growth equity firm in Newport Beach focusing on lifestyle healthcare and cash-pay medical products. He is former president of the medical aesthetics division at Allergan Inc. in Irvine and most recently served as chief executive officer and president of Bausch+Lomb Surgical in Aliso Viejo. He brings extensive experience leading global medical device and pharmaceutical organizations.

"Robert is a visionary leader and strategist and we are delighted that he is joining the team," said Richard Thompson, ReShape Medical president and CEO. "His expertise with cash-pay, elective medical procedures will be invaluable as we move toward commercialization."  ReShape Medical is preparing to begin a pivotal clinical study to gain approval in the U.S. and launched commercially in Europe earlier this year.

Grant said, "I strongly believe there is a huge market opportunity for non-surgical weight loss devices and also that ReShape Medical is well positioned to be the market leader. I am honored to be joining the talented and experienced ReShape board."    

In addition to Grant, ReShape Medical's board of directors consists of: Ken Charhut (Chairman), President and CEO of Mindframe Inc.; Jeani Delagardelle, Managing Director of New Leaf Venture Partners; Casey Tansey, General Partner at US Venture Partners; David Milne, Managing Partner at SV Life Sciences; George Wallace, Managing General Partner for Intersect Partners LLC; and Richard Thompson, President and CEO of ReShape Medical.

About ReShape Medical, Inc.
ReShape Medical® is a medical device manufacturer headquartered in Southern California. The company specializes in a dual-intragastric balloon for weight loss, ReShape Duo®, to be used as an aid in the treatment of obese or overweight patients. ReShape Duo is a non-surgical alternative designed for those who have exhausted their efforts with diet alone and wish to avoid or do not qualify for surgery. It comfortably occupies existing space in the stomach for six months, serving as built in portion control, to help patients feel full and satisfied with less food. CAUTION - Limited by United States law to investigational use.


'/>"/>
SOURCE ReShape Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
2. Medical Device Developers - Network at BIOMEDevice Boston Next Week
3. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
4. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
5. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
6. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
7. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
8. Essential Medical Dismisses Patent Case against Masimo and Cercacor
9. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
10. Aethlon Medical Note: Marc Robins Joins the Aethlon Team
11. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation announce a ... sensors for real-time monitoring of patients with trauma-related and ... focused on disruptive health solutions for rare disorders and ... record and integrate behavioral, cognitive, physiological and contextual data. ... ...
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017  DarioHealth ... and big data solutions, today announced that its MyDario product is expected ... local TV listings for when The Dr. Oz Show airs in your ... The nine-time Emmy ... ...
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
Breaking Medicine Technology:
(Date:10/13/2017)... Milwaukee, WI (PRWEB) , ... October 13, 2017 , ... ... movement in medicine known as “patient engagement.” The patient is doing more than filling ... research partners. , “There is an increasing emphasis in health care and research ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with clinical ... the primary prevention of cardiovascular diseases during the 15th Annual Women’s Health ...
(Date:10/13/2017)... ... 13, 2017 , ... Ellevate Network, the leading network for professional women, brought ... gender equality at their inaugural Summit in New York City in June. The event ... audience of over 3 million. To watch the Mobilize Women video, click here ...
(Date:10/13/2017)... ... 13, 2017 , ... “The Journey: From the Mountains to the Mission Field”: ... souls in the Philippines. “The Journey: From the Mountains to the Mission Field” is ... Bible. She has taught all ages and currently teaches a class of ladies at ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
Breaking Medicine News(10 mins):